Clinical Trial Update: Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sequential administration of oral 6-thioguanine after methotrexate in patients with Langerhans cell histiocytosis; the study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• 6-thioguanine (6-thioguanine)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: COMPLETED | Results posted: 2015-05-04